How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes

Stopped early

Conditions studied: Autoimmunity, Melanoma, Merkel Cell Carcinoma, Squamous Cell Carcinoma of the Skin, Basal Cell Carcinoma, Skin Cancer

In brief

The purpose of this research study is to examine the relationship between the microbiota (microscopic organisms) in the gut and the activity of the immune system during skin cancer immunotherapy.

Key facts

Study ID

NCT03370861

Run by

Washington University School of Medicine

People needed

54

Starts

2017-11-08

Expected to finish

2022-12-31

Last updated by the study team

2024-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥18 years of age.
• Diagnosis of skin cancer.
• Planning to initiate or already on ANY type of immunotherapy.
• Able to provide urine and stool specimens.

You may not qualify if…

• Bowel resection.
• Major GI surgery in the past 5 years other than cholecystectomy and appendectomy.

Where it is running

• Barnes-Jewish Hosptial — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.